References
- Priebe M M, Sherwood A M, Graves D E, Mueller M, Olson W H. Effectiveness of gabapentin in controlling spasticity: A quantitative study. Spinal Cord 1997; 35(3)171–175
- Cutter N C, Scott D D, Johnson J C, Whiteneck G. Gabapentin effect on spasticity in multiple sclerosis: A placebo-controlled, randomized trial. Arch Phys Med Rehabil 2000; 81(2)164–169
- National Collaborating Centre for Chronic Conditions. Multiple Sclerosis; National Clinical Guidelines for Diagnosis and Management in Primary and Secondary Care. 106. 2003. London
- French J A, Kugler A R, Robbins J L, Knapp L E, Garofalo E A. Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures. Neurology 2003; 60(10)1631–1637
- Rosenstock J, Tuchman M, LaMoreaux L, Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 2004; 110(3)628–638
- Fink K, Dooley D J, Meder W P, Suman-Chauhan N, Duffy S, Clusmann H, et al. Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology 2002; 42(2)229–236
- Bryans J S, Wustrow D J. 3-substituted GABA analogs with central nervous system activity: A review. Med Res Rev 1999; 19(2)149–177
- Barbara J deLateur. Evaluation of the effect of pregabalin on spasticity and function in transverse myelitis patients. 2006 Rare Neuroimmunologic Disorders Symposium. 20 July, 2006, Available at www.myelitis.org/rnds2006/index.htm (Accessed 22 August 2007)
- Mehrholz J, Wagner K, Meissner D, Grundmann K, Zange C, Koch R, et al. Reliability of the Modified Tardieu Scale and the Modified Ashworth Scale in adult patients with severe brain injury: A comparison study. Clin Rehabil 2005; 19(7)751–759
- Haugh A B, Pandyan A D, Johnson G R. A systematic review of the Tardieu Scale for the measurement of spasticity. Disabil Rehabil 2006; 28(15)899–907